Diagnostic Assay Development for Poliovirus Eradication
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
With poliovirus eradication nearing, few pockets of active wild poliovirus (WPV) transmission remain in the world. Intratypic differentiation (ITD) plays a crucial part in laboratory surveillance as the molecular detection method that can identify and distinguish wild and vaccine-like polioviruses isolated from acute flaccid paralysis cases or environmental sources. The need to detect new variants of WPV serotype 1 (WPV1) and the containment of all serotype 2 polioviruses (PV2) in 2015 required changes to the previous version of the method. The ITD version 5.0 is a set of six real-time reverse transcription-PCR (rRT-PCR) assays that serve as accurate diagnostic tools to easily detect and differentiate PV serotypes and genotypes. We describe the creation and properties of quantitation standards, including 16 control RNA transcripts and nine plaque-isolated viruses. All ITD rRT-PCR assays were validated using these standards, and the limits of detection were determined for each assay. We designed and pilot tested two new assays targeting recently circulating WPV1 genotypes and all PV2 viruses. The WPV1 assay had 99.1% specificity and 100% sensitivity, and the PV2 assay had 97.7% specificity and 92% sensitivity. Before proceeding to the next step in the global poliovirus eradication program, we needed to gain a better understanding of the performance of the ITD 5.0 suite of molecular assays and their limits of detection and specificities. The findings and conclusions in this evaluation serve as building blocks for future development work.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205 · cited 1×
“A maximum composite likelihood phylogenetic tree was constructed in MEGA version 6 (19), and representative iVDPV2 viruses were selected for PV2 assay development (data not shown).”
MethodHall, T. A. (1999) · Nucleic Acids Symposium Series · doi:10.14601/phytopathol_mediterr-14998u1.29 · Cited by 38,297 · cited 1×
“AY184220), were aligned in BioEdit (18).”
Mendelsohn, C. L., Wimmer, E., & Racaniello, V. R. (1989) · Cell · doi:10.1016/0092-8674(89)90690-9 · Cited by 1,111 · cited 9×
“Multisite validation of ITD 5.0 in GPLN consistently showed results identical to or better than those from previous ITD versions.”
InfluentialKew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600 · cited 1×
“VDPVs are phenotypically equivalent to WPV and may cause paralysis and circulate in areas with immunity gaps (13, 14).”
BackgroundSelf-citationComplete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 418
Statistical Methods for the Social and Behavioral Sciences.
Stallings, W. M., Marascuilo, L. A., & Serlin, R. C. (1989) · Journal of the American Statistical Association · doi:10.2307/2289907 · Cited by 368
Cultivation in vitro of cells derived from a human rhabdomyosarcoma
McAllister, R. M., Melnyk, J., Finklestein, J. Z., Adams, E. C., & Gardner, M. B. (1969) · Cancer · doi:10.1002/1097-0142(196909)24:3<520::aid-cncr2820240313>3.0.co;2-m · Cited by 323 · cited 9×
“Multisite validation of ITD 5.0 in GPLN consistently showed results identical to or better than those from previous ITD versions.”
InfluentialBurns, C. C., Shaw, J., Campagnoli, R., Jorba, J., Vincent, A., Quay, J., & Kew, O. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3259-3272.2006 · Cited by 259 · cited 1×
“Polioviruses representing each of the three serotypes were plaque purified using an adaptation of previously published methods (20, 21).”
MethodKilpatrick, D. R., Yang, C.-F., Ching, K., Vincent, A., Iber, J., Campagnoli, R., Mandelbaum, M., De, L., Yang, S.-J., Nix, A., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00702-09 · Cited by 187 · cited 1×
“To avoid the long run times and complex reagent preparation required by older methods (10), we replaced the previous buffer system with commercially available rRT-PCR enzyme master mix and simplified the thermocycler run method.”
MethodSelf-citationCalibration of multiple poliovirus molecular clocks covering an extended evolutionary range
Jorba, J., Campagnoli, R., De, L., & Kew, O. (2008) · Journal of Virology · doi:10.1128/jvi.02354-07 · Cited by 177
Research works printed but not linked: 6
- WHO. 15 February 2017. Polio this week. WHO, Geneva, Switzerland. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx. Accessed 17 February 2017.
- WHO. 2007. S1. Supplement to the WHO Polio Laboratory Manual: an alternative test algorithm for poliovirus isolation and characterization. WHO, Geneva, Switzerland. http://polioeradication.org/wp-content/uploads/2017/05/NewAlgorithmForPoliovirusIsolationSupplement1.pdf.
- WHO. 2015. The 21st Informal Consultation on the Global Polio Laboratory Network 25. WHO, Geneva, Switzerland. http://polioeradication.org/wp-content/uploads/2016/07/GPLN_Meeting_recommendations_2015.pdf. Accessed 25 May 2017.
- WHO. 20 September 2015. Global eradication of wild poliovirus type 2 declared. WHO, Geneva, Switzerland. http://polioeradication.org/news-post/global-eradication-of-wild-poliovirus-type-2-declared/. Accessed 13 November 2016.
- WHO. March 2017. Fact sheet: vaccine-derived poliovirus. WHO, Geneva, Switzerland. http://polioeradication.org/wp-content/uploads/2016/07/GPEI-cVDPV-factsheet_March-2017.pdf.
- WHO. 2015. WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use. WHO, Geneva, Switzerland. http://polioeradication.org/wp-content/uploads/2016/09/GAPIII_2014.pdf.
Cited by
Brouwer, A. F., Eisenberg, J. N. S., Pomeroy, C. D., Shulman, L. M., Hindiyeh, M. Y., Manor, Y., Grotto, I., Koopman, J. S., & Eisenberg, M. C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808798115 · Cited by 162
“However, the current standard method of environmental surveillance of polio is the tissue-culture–based intratypic differentiation (ITD) assay, which is slower than direct qPCR and not quantitative (52, 53).”
MethodRyerson, A. B., Lang, D., Alazawi, M. A., Neyra, M., Hill, D., George, K. S., Fuschino, M. E., Lutterloh, E. C., Backenson, B. P., Rulli, S. J., et al. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7144e2 · Cited by 90
“Cultures exhibiting viral cytopathic effect were screened by real-time RT-PCR to identify polioviruses (4) and sequenced as described.”
MethodSelf-citationIvanova, O. E., Yarmolskaya, M. S., Eremeeva, T. P., Gm, B., Baykova, O. Y., Akhmadishina, L. V., Krasota, A. Y., Kozlovskaya, L. I., & Lukashev, A. N. (2019) · Viruses · doi:10.3390/v11050424 · Cited by 64
Kew, O. M., & Pallansch, M. A. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041749 · Cited by 49
Sun, H., Harrington, C., Gerloff, N. A., Mandelbaum, M., Miles, S. J., Apostol, L. N. G., Valencia, M. A.-L. D., Shaukat, S., Angez, M., Sharma, D. K., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255795 · Cited by 36
“The LOD and ITD reactions were run as previously described [7].”
MethodSelf-citation
Metadata
- Authors
- Gerloff, N., Sun, H., Mandelbaum, M., Maher, C., Nix, W. A., Zaidi, S., Shaukat, S., Seakamela, L., Nalavade, U. P., Sharma, D. K., Oberste, M. S., & Vega, E.
- Affiliations
- Centers for Disease Control and Prevention (US)
- IHRC, Inc., Atlanta, Georgia, USA
- National Institute of Health (PK)
- National Institute for Communicable Diseases (ZA)
- Enterovirus Research Centre, Mumbai, India
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2018-02
- Volume
- 56
- Issue
- 2
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5786708
- OpenAlex
- W2774178390
- Cited by
- 72
- References
- 25
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 14 · 2023: 9 · 2022: 4 · 2021: 10 · 2020: 7 · 2019: 5 · 2018: 4
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- polio eradication, real-time RT-PCR assay, acute flaccid paralysis surveillance, molecular diagnosis, assay validation, detection limit
- MeSH terms
- Genotype, Humans, Poliomyelitis, Poliovirus Vaccine, Oral, RNA, Viral, Sensitivity and Specificity, Reproducibility of Results, Poliovirus, Reverse Transcriptase Polymerase Chain Reaction, Molecular Typing, Disease Eradication, Epidemiological Monitoring, Serogroup
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic Assay Development for Poliovirus Eradication. https://app.cochat.ai/papers/10.1128/jcm.01624-17
- The paper
- Gerloff, N., Sun, H., Mandelbaum, M., Maher, C., Nix, W. A., Zaidi, S., Shaukat, S., Seakamela, L., Nalavade, U. P., Sharma, D. K., Oberste, M. S., & Vega, E. (2018). Diagnostic Assay Development for Poliovirus Eradication. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01624-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.